Structure-based discovery of a novel allosteric activator of ATG4B for the treatment of triple-negative breast cancer

Puntos clave

• Enhanced activity of ATG4B was achieved with the novel allosteric activator, indicating a promising treatment for cancer.
• The study identified this activator by employing structure-based techniques, focusing on detailed molecular interactions.
• Assessment used advanced modeling and simulations to predict the efficacy of the activator across various cancer cell lines.
• Implications highlight the need for further research to evaluate the potential of this approach in clinical settings.